Comparison of two different dosing intervals of second trimester abortio
Not Applicable
- Conditions
- Health Condition 1: O359- Maternal care for (suspected) fetal abnormality and damage, unspecified
- Registration Number
- CTRI/2023/01/048673
- Lead Sponsor
- O MONETARY SUPPORT
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 Maternal age between 18 to 45 years
2 Singleton pregnancy
3 Willing to participate in the study and ready to comply with the schedule of follow up visits
Exclusion Criteria
1 Unmarried women
2 Multifoetal pregnancy
3 Lactating mothers
4 Previous uterine scars of any type
5 Any contraindication to Mifepristone i.e chronic adrenal failure,long term corticosteroid therapy, concurrent anticoagulant therapy,inherited porphyrias,undiagnosed adnexal mass
6 Any contraindication to Misoprostol i.e severe asthma, glaucoma,pelvic infections,hemodynamic instability,allergy to misoprostol,known bleeding disorder.
7 Uncontrolled hypertension with BP >160/110 mm hg
8 Any acute medical illness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method INDUCTION TO EXPULSION INTERVALTimepoint: TIME INTERVAL BETWEEN INDUCTION WITH TAB MIFEPRISTONE AND EXPULSION OF PRODUCTS OF CONCEPTIO
- Secondary Outcome Measures
Name Time Method To compare the completeness of abortion and to compare the side effects between the two regimenTimepoint: SIDE EFFECTS ASESSED EVERY 3 HOURLY AFTER INDUCTION WITH TAB MISOPROSTO